Invivyd, Inc. (IVVD)
2.51
+0.04
(+1.62%)
USD |
NASDAQ |
Jan 02, 16:00
2.51
0.00 (0.00%)
After-Hours: 16:14
Invivyd Research and Development Expense (TTM): 46.17M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 142.29M |
| Relmada Therapeutics, Inc. | 29.81M |
| Arcellx, Inc. | 168.16M |
| ADMA Biologics, Inc. | 3.776M |
| Cidara Therapeutics, Inc. | 131.82M |